Skip to main content

Global Cardiovascular Devices Market to Grow at 7% CAGR as Digital Health Innovations Rise by 2030

 


The cardiovascular devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors driving growth include increased prevalence of cardiovascular diseases (CVDs), rising demand for minimally invasive procedures, growing aging population, advancement in medical technology, and rising awareness about cardiovascular health conditions. However, the market encounters certain challenges, including the high cost of cardiovascular devices limiting accessibility in low-income regions, stringent regulatory approvals and compliance requirements, and risk associated with device failure and complications during surgical interventions.

Cardiovascular devices are medical devices and tools designed to diagnose, monitor, and treat diseases and conditions affecting the heart and blood vessels (cardiovascular system). These devices are used to manage various cardiovascular disorders, including heart disease, arrhythmias, heart failure, and vascular abnormalities. These devices play a crucial role in improving patient outcomes and quality of life by enabling early detection, effective treatment, and continuous care for cardiovascular conditions.

Download a free sample report for in-depth market insights

https://meditechinsights.com/cardiovascular-devices-market/request-sample/

Growing demand for minimally invasive cardiac procedures drives market growth

Minimally invasive cardiac procedures have transformed heart surgery by providing patients with safer and less invasive alternatives to traditional open-heart surgery. The adoption of these techniques is rapidly increasing, driven by the goals of minimizing patient trauma, reducing recovery times, and lowering healthcare costs. Procedures such as cardiac catheterization and percutaneous coronary intervention are becoming more prevalent due to their significant advantages over conventional methods. These techniques rely on specialized cardiology devices, including catheters, stents, and guidewires, which are experiencing growing demand. Additionally, minimally invasive approaches are widely utilized in a variety of cardiac surgeries, such as mitral valve repair, coronary artery bypass grafting, and aortic valve replacement, further fueling the demand for cardiovascular devices in the market.

Advancements in digital health technologies fuel its demand in the market

The integration of digital health technologies is transforming cardiology, particularly in the diagnosis, treatment, and management of cardiovascular diseases (CVDs). Rapid advancements in wearable devices, artificial intelligence (AI), and telemedicine are enabling more precise, predictive, and personalized care strategies, reshaping the landscape of cardiovascular health. Wearable technologies, such as smartwatches with electrocardiogram (ECG) capabilities, have enhanced early detection of arrhythmias, including atrial fibrillation (AF), improving patient outcomes through timely interventions. Similarly, AI-driven diagnostic tools and machine learning (ML) models are achieving higher accuracy in interpreting ECGs and detecting complex arrhythmias, often surpassing traditional methods. Telehealth has also surged in popularity, especially during the COVID-19 pandemic, by enabling remote monitoring of chronic CVDs. Devices such as implantable pacemakers and defibrillators have further reduced mortality rates by delivering real-time data to healthcare providers, facilitating early and effective interventions.

Competitive Landscape Analysis

The global cardiovascular devices market is marked by the presence of established and emerging market players such as Abbott Laboratories; GE HealthCare; Edwards Lifesciences Corporation; W. L. Gore & Associates, Inc.; Siemens Healthineers; BIOTRONIK SE & Co. KG; Terumo Corporation; Johnson & Johnson; Penumbra, Inc.; Philips Healthcare; Canon Medical Systems Asia Pte. Ltd.; B. Braun SE; LivaNova PLC; Cardinal Health; Medtronic; Boston Scientific Corporation among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.

Unlock key data with a sample report for competitive analysis:

https://meditechinsights.com/cardiovascular-devices-market/request-sample/

Global Cardiovascular Devices Market Segmentation

This report by Medi-Tech Insights provides the size of the global cardiovascular devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product type and end user.

Market Size & Forecast (2023-2030), By Product Type, USD Million

  • Diagnostics & Monitoring Devices
    • ECG
    • Holter Monitors
    • Event Monitors
    • Implantable Cardiac Monitor
    • Echocardiogram
    • PET Scanner
    • MRI
    • Cardiac CT
    • Cardiac Diagnostics Catheters
    • Cardiovascular Ultrasound
    • Others
  • Therapeutic and Surgical Devices
    • Pacemakers
    • Implantable Cardioverter Defibrillators (ICDs)
    • Coronary Stents
    • Catheters and accessories
    • Guidewires
    • Cannula
    • Electrosurgical Procedures
    • Valves
    • Occlusion Devices
    • Others

Market Size & Forecast (2023-2030), By End User, USD Million

  • Hospitals
  • Clinics
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...
Post a Comment
Read more